Fortis Healthcare Share News - Latest Updates, Live News & More

Latest news about Fortis Healthcare

Fortis Healthcare Amends Terms of Non-Convertible Debentures 13 hours ago Yesterday

Fortis Healthcare has announced changes to the terms of its non-convertible debentures (NCDs). The modifications are part of the company's efforts to optimize its financial structure and improve its debt profile. While specific details are not provided, such changes typically aim to improve debt-to-equity ratios, extend maturity dates, adjust interest rates, or enhance financial flexibility. The alterations may impact the company's financial obligations, cash flow, and potentially affect investors' expected returns or investment timelines.

Fortis Healthcare Reports 17.3% Revenue Growth in Q2 FY26, Driven by Strong Hospital Performance Nov 18, 2025

Fortis Healthcare Reports Robust Q2 FY26 Performance with 17.3% Revenue Growth and Margin Expansion Nov 17, 2025

IHH Healthcare Concludes Open Offers for Fortis Healthcare and Fortis Malar with Minimal Shareholder Participation Nov 11, 2025

Fortis Healthcare Announces Open Offer Tendering Period for Fortis and Malar Hospitals Oct 16, 2025

More news about Fortis Healthcare

16Oct 25

Fortis Healthcare Seeks Shareholder Approval for Dr. Keith Hsiu Chin Lim's Board Appointment

Fortis Healthcare has initiated a postal ballot to ratify Dr. Keith Hsiu Chin Lim's appointment as a Non-Independent & Non-Executive Director. Dr. Lim, nominated by Northern TK Venture Pte. Limited, was initially appointed as an Additional Director on September 09, 2025. Shareholders can vote from October 17 to November 15, 2025, with results expected by November 18. Dr. Lim, currently Group Chief Medical Officer at IHH Healthcare, brings over 20 years of experience as a radiation oncologist and has held key positions in healthcare management and policy.

06Oct 25

Fortis Healthcare Shares Surge as IHH Healthcare Gets SEBI Nod for Long-Awaited Open Offer

Fortis Healthcare shares rose 3% after SEBI approved Malaysia-based IHH Healthcare Berhad's open offer to acquire an additional 26% stake. This approval comes after a long delay since 2018 due to legal complications. The original offer price was ₹170 per share, but Fortis' current trading price is around ₹980, a 4.7x increase. At current prices, the open offer could amount to approximately ₹19,308 crore. Fortis stock has shown strong momentum, up 2.80% on the latest trading day and 7% over the past month.

03Oct 25

SEBI Greenlights IHH Healthcare's Open Offer for Fortis Healthcare and Fortis Malar Hospitals

IHH Healthcare Berhad received SEBI approval for open offers to acquire stakes in Fortis Healthcare and Fortis Malar Hospitals. The transaction includes a preferential allotment of 235,294,117 new Fortis shares to IHH's subsidiary, and mandatory open offers for up to 26.10% of Fortis Healthcare and 26.11% of Fortis Malar Hospitals. This approval ends a regulatory delay since 2018, potentially reshaping India's private healthcare sector.

01Oct 25

Fortis Healthcare Inks O&M Agreement for Gleneagles BGS Hospital, Effective October 2025

Fortis Healthcare Limited has signed an Operations and Maintenance (O&M) agreement for Gleneagles BGS Hospital in Karnataka, effective from October 1, 2025. The agreement, disclosed through a regulatory filing, follows an earlier intimation made on July 23, 2025. The company confirmed that all necessary acceptances and No Objection Certificates from relevant third parties have been obtained, allowing the agreement to proceed as planned.

09Sept 25

Fortis Healthcare Announces Board Changes: Dr. Keith Lim Joins, Tomo Nagahiro Departs

Fortis Healthcare Limited has appointed Dr. Keith Hsiu Chin Lim as an Additional Director (Non-Executive & Non-Independent) effective September 09, 2025. Simultaneously, Tomo Nagahiro has resigned from his position as Non-Executive & Non-Independent Director. Dr. Lim, currently Group Chief Medical Officer at IHH Healthcare, brings over 20 years of experience as a radiation oncologist. He serves as a nominee director of Northern TK Venture Pte. Ltd., along with several other board members.

05Sept 25

Fortis Healthcare Inks Hospital Land and Equipment Lease Deal in Greater Noida

Fortis Healthcare has entered into a strategic agreement for hospital land and equipment lease in Greater Noida, expanding its presence in the National Capital Region (NCR). The agreement involves Fortis Healthcare, Uttar Pradesh State Industrial Development Authority (UPSIDA), and R.R. Lifesciences Pvt Ltd. This move allows Fortis to establish a presence in the growing Greater Noida area, potentially tapping into a new patient base. The company is adopting an asset-light approach by leasing rather than purchasing, which could be more cost-effective in the short term.

02Sept 25

Fortis Healthcare Expands Delhi-NCR Footprint with 200-Bed Greater Noida Hospital

Fortis Healthcare's subsidiary, International Hospital Limited, has leased a 200-bed multi-specialty hospital in Greater Noida for 15 years. This expansion increases Fortis' bed capacity in Delhi-NCR to about 2,000. The facility has potential for 50 additional beds. IHL will pay a monthly rent of Rs. 2.40 crore plus GST, with a Rs. 60 crore refundable security deposit. The strategically located hospital is well-connected and near the upcoming Jewar International Airport. Fortis has also completed a corporate restructuring process involving its subsidiaries.

06Aug 25

Fortis Healthcare Reports Strong Q1 FY26 Results, Unveils Ambitious Expansion Plans

Fortis Healthcare reported robust Q1 FY26 results with 16.60% revenue growth to INR 2,167.00 crore and 56.80% PAT growth to INR 260.00 crore. The hospital business saw 18.60% revenue growth, while diagnostics arm Agilus grew by 7.40%. Fortis announced expansion plans including an O&M agreement with Gleneagles India for managing 700 beds, acquisition of Shrimann Superspecialty Hospital adding 228 beds, and aims to add over 1,000 new beds. The company is focusing on high-profit specialties and increasing international patient revenue.

06Aug 25

Fortis Healthcare Reports Robust Q1 FY26 Results with 16.6% Revenue Growth

Fortis Healthcare announced robust financial results for Q1 FY26. Consolidated revenues increased by 16.6% to INR 2,167.00 crore. Operating EBITDA surged 43.2% to INR 491.00 crore, with margin expanding to 22.6%. PAT grew 56.8% to INR 260.00 crore. Hospital business revenues rose 18.6% to INR 1,838.00 crore, while diagnostics arm Agilus saw 7.4% revenue growth. The company entered an O&M agreement with Gleneagles India and acquired Shrimann Superspecialty Hospital in Jalandhar.

31Jul 25

Fortis Healthcare Receives NCLT Approval for Subsidiary Restructuring Scheme

Fortis Healthcare Limited has received approval from NCLTs in New Delhi and Chandigarh for a composite scheme of arrangement involving three wholly-owned subsidiaries: International Hospital Limited, Fortis Hospitals Limited, and Fortis Hospotel Limited. The restructuring, with an appointed date of April 1, 2023, aims to streamline the company's complex corporate structure and enhance operational efficiency. The involved subsidiaries have a combined paid-up capital of INR 9,708.01 million and a total turnover of INR 50,298.26 million. The scheme is expected to reduce administrative, operational, and financial inefficiencies without impacting Fortis Healthcare's shareholding pattern.

24Jul 25

Fortis Healthcare Subsidiary Completes Acquisition of Shrimann Superspecialty Hospital

Fortis Healthcare's subsidiary, Fortis Hospotel Limited (FHTL), has completed the acquisition of Shrimann Superspecialty Hospital's entire business operations, including hospital land and adjacent property. The transaction was finalized on July 24, 2025, at 09:14 PM IST. This acquisition follows earlier announcements made to stock exchanges in February, March, and May 2025. Fortis Healthcare has informed the National Stock Exchange of India Ltd. and BSE Limited about the transaction completion, in compliance with SEBI regulations.

24Jul 25

Fortis Healthcare Shares Soar to Record High on Landmark Gleneagles Hospital Management Deal

Fortis Healthcare's shares reached a new all-time high of Rs 839.90 following the announcement of a strategic collaboration with IHH Healthcare Berhad. The company signed an operation and maintenance services agreement to manage five out of six hospitals under the Gleneagles India network. Fortis will receive a monthly service fee of 3% of the net revenue of the hospitals. The deal aims to strengthen IHH's business in India and unlock operational and financial synergies. The market responded positively, with Fortis shares rising 1.97% and trading volume 3.8 times the 30-day average. Analysts maintain a largely positive outlook on the stock.

21Jul 25

Agilus Secures 'SRL' Trademarks for ₹8 Crore in Delhi High Court Auction

Agilus Diagnostics Limited, a subsidiary of Fortis Healthcare, has successfully purchased the 'SRL' trademarks for ₹8.00 crore through a court-sanctioned auction conducted by the Delhi High Court. The trademarks were previously owned by RHC Holding Private Limited and were made available for auction to satisfy a decree in favor of Daiichi Sankyo Company Limited. The acquisition follows a complex legal process involving multiple parties and is part of a larger dispute stemming from a 2016 Singapore tribunal arbitral award. Fortis Healthcare stated that there are no additional financial implications due to compensation or penalties arising from this sale.

30Jun 25

Fortis Healthcare Unveils Ambitious Expansion Plans, Targets 14-15% Revenue Growth

Fortis Healthcare plans to add 900 beds in the coming year as part of its expansion strategy. The company targets 14-15% revenue growth for FY26. Its hospital segment showed 14% year-over-year revenue growth in Q4 FY25 with improved occupancy rates and increased ARPOB. The diagnostics segment has been rebranded as 'Agilus' with expectations of stronger performance from FY26. Analysts maintain an 'Outperform' rating on Fortis Healthcare's stock.

21May 25

Fortis Healthcare Reports Q4 Revenue Growth, Targets Higher Margins

Fortis Healthcare's Q4 results show revenue growth of 12.40% to ₹2,007.00 crore, but a 7.40% decrease in net profit to ₹188.00 crore. The company reported an exceptional loss of ₹53.57 crore. Despite challenges, PBT increased by 8.20%. Fortis announced a final dividend of ₹1.00 per share. Quarterly performance shows significant improvements in EBITDA and net profit. The company aims to improve margins by FY26 through maintaining high occupancy, increasing complex procedures, and adding 800 new beds this year.

20May 25

Fortis Healthcare Q4: Net Profit Drops 7%, Revenue Surges, Dividend Recommended

Fortis Healthcare's Q4 results show a 12.4% YoY revenue increase to ₹2,007.20 crore and improved EBITDA of ₹440.00 crore. However, net profit decreased by 7.44% to ₹188.02 crore due to exceptional impairment losses. The board recommended a final dividend of ₹1.00 per equity share.

06May 25

Fortis Healthcare's Tax Demand Nullified: A Win for Subsidiary Fortis Hospitals

Fortis Healthcare Limited announced that its subsidiary, Fortis Hospitals Limited, received a favorable rectification order under the Income Tax Act. The order nullifies a previous tax demand of Rs. 89.53 crores for the Assessment Year 2022-23. The rectification, issued on May 05, 2025, corrects mistakes in the earlier assessment order. Fortis Healthcare stated this development would not impact its financial or operational activities in quantifiable monetary terms.

06May 25

Fortis Healthcare Subsidiary's ₹89.53 Crore Tax Demand Nullified

Fortis Healthcare Limited announced that its subsidiary, Fortis Hospitals Limited, received a rectification order from the Income Tax Department. The order reduces a previous tax demand of ₹89.53 crore for the assessment year 2022-23 to nil. The rectification, issued on May 5, 2025, corrects mistakes in the earlier assessment order. Fortis Healthcare stated that this development has no quantifiable impact on the company's financial or operational activities.

05May 25

Fortis Healthcare Receives Favorable Tax Rectification Order, Eliminating ₹89.53 Crore Demand

Fortis Healthcare's subsidiary, Fortis Hospitals Limited, has received a favorable rectification order under the Income Tax Act. The initial tax demand of ₹89.53 crore for the Assessment Year 2022-23 has been reduced to nil. This rectification, issued on May 5, 2025, corrects errors in the original assessment order. Fortis Healthcare states this development will not impact its financial or operational activities in quantifiable monetary terms.

03Apr 25

Fortis Healthcare Subsidiary Faces ₹76.19 Crore Tax Demand, Plans Appeal

International Hospital Limited (IHL), a subsidiary of Fortis Healthcare, has received an income tax demand of ₹76.19 crore for the Assessment Year 2019-20. The demand stems from disallowed interest expenses. IHL is considering appealing the order. Fortis Healthcare states this will not materially impact IHL's financials or operations.

03Apr 25

Fortis Healthcare Secures Ownership of 'Fortis' Brand in Landmark Delhi High Court Ruling

The Delhi High Court has confirmed the sale of 'Fortis' trademarks to Fortis Healthcare Limited for ₹200.00 crore, ending a complex legal dispute. The ruling rejects objections to the valuation and auction process, grants Fortis Healthcare full ownership rights, and allows for trademark registration transfer. The court has scheduled the execution of the sale deed for April 16, 2025.

02Apr 25

Fortis Healthcare Secures 'Fortis' Trademark for Rs 200 Crore in Delhi High Court Ruling

Fortis Healthcare Limited has won a significant legal battle, obtaining full ownership of its brand name and associated trademarks. The Delhi High Court confirmed the sale of the 'Fortis' marks to the healthcare provider for Rs 200.00 crore. This decision follows a Supreme Court judgment from September 2022 that made these trademarks available for satisfying a decree in favor of Daiichi Sankyo Company Limited. The acquisition allows Fortis Healthcare to solidify its brand identity, potentially enhancing its market value and investor confidence.

24Mar 25

Fortis Healthcare Faces Legal Hurdle in Shrimann Hospital Sale

Fortis Healthcare faces a legal setback as an ex-parte injunction order stops the planned sale of Shrimann Hospital. Shrimann Hospital is seeking an amicable settlement to vacate the order. This legal obstacle could impact Fortis's strategic plans, financial projections, and investor sentiment. The healthcare sector is closely watching the situation's resolution and its potential effects on Fortis's performance and growth strategy.

21Mar 25

Fortis Healthcare Faces Legal Hurdle in Shrimann Hospital Acquisition

Fortis Healthcare Limited's planned acquisition of Shrimann Hospital in Jalandhar has been temporarily halted by an ex-parte injunction order issued on March 20, 2025. The order stems from a petition filed by Cancer Treatment Services Hyderabad Private Limited against Shrimann Hospital regarding alleged dues. Fortis Healthcare, not a party to the litigation, reports that Shrimann Hospital is seeking an amicable settlement and vacation of the injunction. This legal obstacle comes despite recent shareholder approval for the acquisition and related financial arrangements.

06Mar 25

Fortis Healthcare Sees Significant Block Trade on NSE

A significant block trade of 561,829 Fortis Healthcare shares occurred on the National Stock Exchange at Rs. 665.55 per share, totaling Rs. 37.39 crores. This large transaction could potentially indicate shifts in investor holdings or market sentiments towards the company, although the identities of the buyer and seller remain undisclosed.